Article Information
PubMed
Print ISSN
Online ISSN
History
- Received August 30, 2005
- Accepted January 3, 2006
- Published online March 21, 2006.
Article Versions
- Earlier version (January 5, 2006 - 12:04).
- You are viewing the most recent version of this article.
Copyright & Usage
The American Society for Pharmacology and Experimental Therapeutics
Author Information
- Laxiang Wan,
- Deliang Cao,
- Jianmin Zeng,
- Ruilan Yan and
- Giuseppe Pizzorno
- Department of Internal Medicine, Section of Medical Oncology, Yale University School of Medicine, New Haven, Connecticut (L.W., J.Z., G.P.); Department of Medical Microbiology, Immunology, and Cell Biology, Southern Illinois University School of Medicine, Springfield, Illinois (D.C., R.Y.); and Nevada Cancer Institute, Las Vegas, Nevada (G.P.)
- Address correspondence to:
Dr. Giuseppe Pizzorno, Department of Internal Medicine (Oncology), Yale University School of Medicine, 333 Cedar Street, SHM I 220, New Haven, CT 06520. E-mail: giuseppe.pizzorno{at}yale.edu
Statistics from Altmetric.com
Article usage
In this issue
Modulation of Uridine Phosphorylase Gene Expression by Tumor Necrosis Factor-α Enhances the Antiproliferative Activity of the Capecitabine Intermediate 5′-Deoxy-5-fluorouridine in Breast Cancer Cells
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement